Another recent study assessed the prognostic value of epithelial cell transforming 2 (ECT2) in NSCLC and observed that increased ECT2 expression might independently predict poor OS and RFS in LUAD, but not in lung squamous cell carcinoma [17]. This evidence concerns the gene ECT2 and squamous cell lung carcinoma.